Global Biobanking research
Global Biobanking research

Biobanking Comprehensive Study by Type (Equipment, Consumables, Services, Software), Application (Regenerative Medicine, Life Science Research, Clinical Research), Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private Organization), Biobank Type (Population-based Biobanks, Disease-oriented Biobanks), Specimen Type (Blood Products, Solid Tissue, Nucleic Acid, Cell Lines) Players and Region - Global Market Outlook to 2025

Biobanking Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Dec 2020 Edition 216 Pages 166 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Biobanking Market?

The global biobanking market was valued at around 35 billion US dollars in 2019 and it is estimated to reach 50 billion US dollars by 2025. Artificial Intelligence (AI)-driven process automation, robotics, data analytics, the internet, and other rapidly emerging technological advances are driving the global biobanking market. Biobanking refers to the process by which samples of bodily fluid or tissue(usually human) are collected for research purposes to improve our understanding of health and disease.

The market study is being classified by Type (Equipment, Consumables, Services and Software), by Application (Regenerative Medicine, Life Science Research and Clinical Research) and major geographies with country level break-up.

Hamilton Company (United States), Brooks Automation (United States), Qiagen N.V. (Germany), TTP Labtech Ltd (United Kingdom), VWR Corporation (United States), Thermo Fisher Scientific Inc. (United States), Tecan Group Ltd. (Switzerland), Promega Corporation (United States), Worthington Industries (United States), Chart Industries (United Sates), Becton, Dickinson and Company (United States) and Merck KGaA (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Modul-Bio (France), CSols Ltd (United Kingdom), Ziath (United Kingdom), LabVantage Solutions Inc. (United States), Greiner Bio-One (Austria), Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (United States), Cell & Co Bioservices (France) and RUCDR infinite biologics (United States).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Biobanking market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Biobanking market by Type, Application and Region.

On the basis of geography, the market of Biobanking has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in Genomic Research Activities for Studying Diseases
  • Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns

Market Trend
  • Government and Private Funding to Support Regenerative Medicine Research
  • Growing Need for Cost-Effective Drug Discovery and Development

Restraints
  • High Cost of Automation
  • Issues Related to Biospecimen Sample Procurement

Opportunities
  • Emerging Countries
  • Growing Focus on the R&D of Cell Therapies

Challenges
  • Long-Term Sustainability of Biobanks





Key Target Audience
Biobanking Companies, Emerging Companies, Research Professionals and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Equipment
  • Consumables
  • Services
  • Software
By Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
By Ownership
  • National/Regional Agencies
  • Nonprofit Organization
  • University, and Private Organization

By Biobank Type
  • Population-based Biobanks
  • Disease-oriented Biobanks

By Specimen Type
  • Blood Products
  • Solid Tissue
  • Nucleic Acid
  • Cell Lines

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Genomic Research Activities for Studying Diseases
      • 3.2.2. Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns
    • 3.3. Market Challenges
      • 3.3.1. Long-Term Sustainability of Biobanks
    • 3.4. Market Trends
      • 3.4.1. Government and Private Funding to Support Regenerative Medicine Research
      • 3.4.2. Growing Need for Cost-Effective Drug Discovery and Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biobanking, by Type, Application, Ownership, Biobank Type, Specimen Type and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Biobanking (Value)
      • 5.2.1. Global Biobanking by: Type (Value)
        • 5.2.1.1. Equipment
        • 5.2.1.2. Consumables
        • 5.2.1.3. Services
        • 5.2.1.4. Software
      • 5.2.2. Global Biobanking by: Application (Value)
        • 5.2.2.1. Regenerative Medicine
        • 5.2.2.2. Life Science Research
        • 5.2.2.3. Clinical Research
      • 5.2.3. Global Biobanking by: Ownership (Value)
        • 5.2.3.1. National/Regional Agencies
        • 5.2.3.2. Nonprofit Organization
        • 5.2.3.3. University, and Private Organization
      • 5.2.4. Global Biobanking by: Biobank Type (Value)
        • 5.2.4.1. Population-based Biobanks
        • 5.2.4.2. Disease-oriented Biobanks
      • 5.2.5. Global Biobanking by: Specimen Type (Value)
        • 5.2.5.1. Blood Products
        • 5.2.5.2. Solid Tissue
        • 5.2.5.3. Nucleic Acid
        • 5.2.5.4. Cell Lines
      • 5.2.6. Global Biobanking Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Biobanking: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Hamilton Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Brooks Automation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Qiagen N.V. (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. TTP Labtech Ltd (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. VWR Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Thermo Fisher Scientific Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tecan Group Ltd. (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Promega Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Worthington Industries (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Chart Industries (United Sates)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Becton, Dickinson and Company (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Merck KGaA (Germany)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Biobanking Sale, by Type, Application, Ownership, Biobank Type, Specimen Type and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Biobanking (Value)
      • 7.2.1. Global Biobanking by: Type (Value)
        • 7.2.1.1. Equipment
        • 7.2.1.2. Consumables
        • 7.2.1.3. Services
        • 7.2.1.4. Software
      • 7.2.2. Global Biobanking by: Application (Value)
        • 7.2.2.1. Regenerative Medicine
        • 7.2.2.2. Life Science Research
        • 7.2.2.3. Clinical Research
      • 7.2.3. Global Biobanking by: Ownership (Value)
        • 7.2.3.1. National/Regional Agencies
        • 7.2.3.2. Nonprofit Organization
        • 7.2.3.3. University, and Private Organization
      • 7.2.4. Global Biobanking by: Biobank Type (Value)
        • 7.2.4.1. Population-based Biobanks
        • 7.2.4.2. Disease-oriented Biobanks
      • 7.2.5. Global Biobanking by: Specimen Type (Value)
        • 7.2.5.1. Blood Products
        • 7.2.5.2. Solid Tissue
        • 7.2.5.3. Nucleic Acid
        • 7.2.5.4. Cell Lines
      • 7.2.6. Global Biobanking Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biobanking: by Type(USD Million)
  • Table 2. Biobanking Equipment , by Region USD Million (2014-2019)
  • Table 3. Biobanking Consumables , by Region USD Million (2014-2019)
  • Table 4. Biobanking Services , by Region USD Million (2014-2019)
  • Table 5. Biobanking Software , by Region USD Million (2014-2019)
  • Table 6. Biobanking: by Application(USD Million)
  • Table 7. Biobanking Regenerative Medicine , by Region USD Million (2014-2019)
  • Table 8. Biobanking Life Science Research , by Region USD Million (2014-2019)
  • Table 9. Biobanking Clinical Research , by Region USD Million (2014-2019)
  • Table 10. Biobanking: by Ownership(USD Million)
  • Table 11. Biobanking National/Regional Agencies , by Region USD Million (2014-2019)
  • Table 12. Biobanking Nonprofit Organization , by Region USD Million (2014-2019)
  • Table 13. Biobanking University, and Private Organization , by Region USD Million (2014-2019)
  • Table 14. Biobanking: by Biobank Type(USD Million)
  • Table 15. Biobanking Population-based Biobanks , by Region USD Million (2014-2019)
  • Table 16. Biobanking Disease-oriented Biobanks , by Region USD Million (2014-2019)
  • Table 17. Biobanking: by Specimen Type(USD Million)
  • Table 18. Biobanking Blood Products , by Region USD Million (2014-2019)
  • Table 19. Biobanking Solid Tissue , by Region USD Million (2014-2019)
  • Table 20. Biobanking Nucleic Acid , by Region USD Million (2014-2019)
  • Table 21. Biobanking Cell Lines , by Region USD Million (2014-2019)
  • Table 22. South America Biobanking, by Country USD Million (2014-2019)
  • Table 23. South America Biobanking, by Type USD Million (2014-2019)
  • Table 24. South America Biobanking, by Application USD Million (2014-2019)
  • Table 25. South America Biobanking, by Ownership USD Million (2014-2019)
  • Table 26. South America Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 27. South America Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 28. Brazil Biobanking, by Type USD Million (2014-2019)
  • Table 29. Brazil Biobanking, by Application USD Million (2014-2019)
  • Table 30. Brazil Biobanking, by Ownership USD Million (2014-2019)
  • Table 31. Brazil Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 32. Brazil Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 33. Argentina Biobanking, by Type USD Million (2014-2019)
  • Table 34. Argentina Biobanking, by Application USD Million (2014-2019)
  • Table 35. Argentina Biobanking, by Ownership USD Million (2014-2019)
  • Table 36. Argentina Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 37. Argentina Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 38. Rest of South America Biobanking, by Type USD Million (2014-2019)
  • Table 39. Rest of South America Biobanking, by Application USD Million (2014-2019)
  • Table 40. Rest of South America Biobanking, by Ownership USD Million (2014-2019)
  • Table 41. Rest of South America Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 42. Rest of South America Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 43. Asia Pacific Biobanking, by Country USD Million (2014-2019)
  • Table 44. Asia Pacific Biobanking, by Type USD Million (2014-2019)
  • Table 45. Asia Pacific Biobanking, by Application USD Million (2014-2019)
  • Table 46. Asia Pacific Biobanking, by Ownership USD Million (2014-2019)
  • Table 47. Asia Pacific Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 48. Asia Pacific Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 49. China Biobanking, by Type USD Million (2014-2019)
  • Table 50. China Biobanking, by Application USD Million (2014-2019)
  • Table 51. China Biobanking, by Ownership USD Million (2014-2019)
  • Table 52. China Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 53. China Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 54. Japan Biobanking, by Type USD Million (2014-2019)
  • Table 55. Japan Biobanking, by Application USD Million (2014-2019)
  • Table 56. Japan Biobanking, by Ownership USD Million (2014-2019)
  • Table 57. Japan Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 58. Japan Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 59. India Biobanking, by Type USD Million (2014-2019)
  • Table 60. India Biobanking, by Application USD Million (2014-2019)
  • Table 61. India Biobanking, by Ownership USD Million (2014-2019)
  • Table 62. India Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 63. India Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 64. South Korea Biobanking, by Type USD Million (2014-2019)
  • Table 65. South Korea Biobanking, by Application USD Million (2014-2019)
  • Table 66. South Korea Biobanking, by Ownership USD Million (2014-2019)
  • Table 67. South Korea Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 68. South Korea Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 69. Taiwan Biobanking, by Type USD Million (2014-2019)
  • Table 70. Taiwan Biobanking, by Application USD Million (2014-2019)
  • Table 71. Taiwan Biobanking, by Ownership USD Million (2014-2019)
  • Table 72. Taiwan Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 73. Taiwan Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 74. Australia Biobanking, by Type USD Million (2014-2019)
  • Table 75. Australia Biobanking, by Application USD Million (2014-2019)
  • Table 76. Australia Biobanking, by Ownership USD Million (2014-2019)
  • Table 77. Australia Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 78. Australia Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 79. Rest of Asia-Pacific Biobanking, by Type USD Million (2014-2019)
  • Table 80. Rest of Asia-Pacific Biobanking, by Application USD Million (2014-2019)
  • Table 81. Rest of Asia-Pacific Biobanking, by Ownership USD Million (2014-2019)
  • Table 82. Rest of Asia-Pacific Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 83. Rest of Asia-Pacific Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 84. Europe Biobanking, by Country USD Million (2014-2019)
  • Table 85. Europe Biobanking, by Type USD Million (2014-2019)
  • Table 86. Europe Biobanking, by Application USD Million (2014-2019)
  • Table 87. Europe Biobanking, by Ownership USD Million (2014-2019)
  • Table 88. Europe Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 89. Europe Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 90. Germany Biobanking, by Type USD Million (2014-2019)
  • Table 91. Germany Biobanking, by Application USD Million (2014-2019)
  • Table 92. Germany Biobanking, by Ownership USD Million (2014-2019)
  • Table 93. Germany Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 94. Germany Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 95. France Biobanking, by Type USD Million (2014-2019)
  • Table 96. France Biobanking, by Application USD Million (2014-2019)
  • Table 97. France Biobanking, by Ownership USD Million (2014-2019)
  • Table 98. France Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 99. France Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 100. Italy Biobanking, by Type USD Million (2014-2019)
  • Table 101. Italy Biobanking, by Application USD Million (2014-2019)
  • Table 102. Italy Biobanking, by Ownership USD Million (2014-2019)
  • Table 103. Italy Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 104. Italy Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 105. United Kingdom Biobanking, by Type USD Million (2014-2019)
  • Table 106. United Kingdom Biobanking, by Application USD Million (2014-2019)
  • Table 107. United Kingdom Biobanking, by Ownership USD Million (2014-2019)
  • Table 108. United Kingdom Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 109. United Kingdom Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 110. Netherlands Biobanking, by Type USD Million (2014-2019)
  • Table 111. Netherlands Biobanking, by Application USD Million (2014-2019)
  • Table 112. Netherlands Biobanking, by Ownership USD Million (2014-2019)
  • Table 113. Netherlands Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 114. Netherlands Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 115. Rest of Europe Biobanking, by Type USD Million (2014-2019)
  • Table 116. Rest of Europe Biobanking, by Application USD Million (2014-2019)
  • Table 117. Rest of Europe Biobanking, by Ownership USD Million (2014-2019)
  • Table 118. Rest of Europe Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 119. Rest of Europe Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 120. MEA Biobanking, by Country USD Million (2014-2019)
  • Table 121. MEA Biobanking, by Type USD Million (2014-2019)
  • Table 122. MEA Biobanking, by Application USD Million (2014-2019)
  • Table 123. MEA Biobanking, by Ownership USD Million (2014-2019)
  • Table 124. MEA Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 125. MEA Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 126. Middle East Biobanking, by Type USD Million (2014-2019)
  • Table 127. Middle East Biobanking, by Application USD Million (2014-2019)
  • Table 128. Middle East Biobanking, by Ownership USD Million (2014-2019)
  • Table 129. Middle East Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 130. Middle East Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 131. Africa Biobanking, by Type USD Million (2014-2019)
  • Table 132. Africa Biobanking, by Application USD Million (2014-2019)
  • Table 133. Africa Biobanking, by Ownership USD Million (2014-2019)
  • Table 134. Africa Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 135. Africa Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 136. North America Biobanking, by Country USD Million (2014-2019)
  • Table 137. North America Biobanking, by Type USD Million (2014-2019)
  • Table 138. North America Biobanking, by Application USD Million (2014-2019)
  • Table 139. North America Biobanking, by Ownership USD Million (2014-2019)
  • Table 140. North America Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 141. North America Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 142. United States Biobanking, by Type USD Million (2014-2019)
  • Table 143. United States Biobanking, by Application USD Million (2014-2019)
  • Table 144. United States Biobanking, by Ownership USD Million (2014-2019)
  • Table 145. United States Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 146. United States Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 147. Canada Biobanking, by Type USD Million (2014-2019)
  • Table 148. Canada Biobanking, by Application USD Million (2014-2019)
  • Table 149. Canada Biobanking, by Ownership USD Million (2014-2019)
  • Table 150. Canada Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 151. Canada Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 152. Mexico Biobanking, by Type USD Million (2014-2019)
  • Table 153. Mexico Biobanking, by Application USD Million (2014-2019)
  • Table 154. Mexico Biobanking, by Ownership USD Million (2014-2019)
  • Table 155. Mexico Biobanking, by Biobank Type USD Million (2014-2019)
  • Table 156. Mexico Biobanking, by Specimen Type USD Million (2014-2019)
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Biobanking: by Type(USD Million)
  • Table 170. Biobanking Equipment , by Region USD Million (2020-2025)
  • Table 171. Biobanking Consumables , by Region USD Million (2020-2025)
  • Table 172. Biobanking Services , by Region USD Million (2020-2025)
  • Table 173. Biobanking Software , by Region USD Million (2020-2025)
  • Table 174. Biobanking: by Application(USD Million)
  • Table 175. Biobanking Regenerative Medicine , by Region USD Million (2020-2025)
  • Table 176. Biobanking Life Science Research , by Region USD Million (2020-2025)
  • Table 177. Biobanking Clinical Research , by Region USD Million (2020-2025)
  • Table 178. Biobanking: by Ownership(USD Million)
  • Table 179. Biobanking National/Regional Agencies , by Region USD Million (2020-2025)
  • Table 180. Biobanking Nonprofit Organization , by Region USD Million (2020-2025)
  • Table 181. Biobanking University, and Private Organization , by Region USD Million (2020-2025)
  • Table 182. Biobanking: by Biobank Type(USD Million)
  • Table 183. Biobanking Population-based Biobanks , by Region USD Million (2020-2025)
  • Table 184. Biobanking Disease-oriented Biobanks , by Region USD Million (2020-2025)
  • Table 185. Biobanking: by Specimen Type(USD Million)
  • Table 186. Biobanking Blood Products , by Region USD Million (2020-2025)
  • Table 187. Biobanking Solid Tissue , by Region USD Million (2020-2025)
  • Table 188. Biobanking Nucleic Acid , by Region USD Million (2020-2025)
  • Table 189. Biobanking Cell Lines , by Region USD Million (2020-2025)
  • Table 190. South America Biobanking, by Country USD Million (2020-2025)
  • Table 191. South America Biobanking, by Type USD Million (2020-2025)
  • Table 192. South America Biobanking, by Application USD Million (2020-2025)
  • Table 193. South America Biobanking, by Ownership USD Million (2020-2025)
  • Table 194. South America Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 195. South America Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 196. Brazil Biobanking, by Type USD Million (2020-2025)
  • Table 197. Brazil Biobanking, by Application USD Million (2020-2025)
  • Table 198. Brazil Biobanking, by Ownership USD Million (2020-2025)
  • Table 199. Brazil Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 200. Brazil Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 201. Argentina Biobanking, by Type USD Million (2020-2025)
  • Table 202. Argentina Biobanking, by Application USD Million (2020-2025)
  • Table 203. Argentina Biobanking, by Ownership USD Million (2020-2025)
  • Table 204. Argentina Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 205. Argentina Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 206. Rest of South America Biobanking, by Type USD Million (2020-2025)
  • Table 207. Rest of South America Biobanking, by Application USD Million (2020-2025)
  • Table 208. Rest of South America Biobanking, by Ownership USD Million (2020-2025)
  • Table 209. Rest of South America Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 210. Rest of South America Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 211. Asia Pacific Biobanking, by Country USD Million (2020-2025)
  • Table 212. Asia Pacific Biobanking, by Type USD Million (2020-2025)
  • Table 213. Asia Pacific Biobanking, by Application USD Million (2020-2025)
  • Table 214. Asia Pacific Biobanking, by Ownership USD Million (2020-2025)
  • Table 215. Asia Pacific Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 216. Asia Pacific Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 217. China Biobanking, by Type USD Million (2020-2025)
  • Table 218. China Biobanking, by Application USD Million (2020-2025)
  • Table 219. China Biobanking, by Ownership USD Million (2020-2025)
  • Table 220. China Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 221. China Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 222. Japan Biobanking, by Type USD Million (2020-2025)
  • Table 223. Japan Biobanking, by Application USD Million (2020-2025)
  • Table 224. Japan Biobanking, by Ownership USD Million (2020-2025)
  • Table 225. Japan Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 226. Japan Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 227. India Biobanking, by Type USD Million (2020-2025)
  • Table 228. India Biobanking, by Application USD Million (2020-2025)
  • Table 229. India Biobanking, by Ownership USD Million (2020-2025)
  • Table 230. India Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 231. India Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 232. South Korea Biobanking, by Type USD Million (2020-2025)
  • Table 233. South Korea Biobanking, by Application USD Million (2020-2025)
  • Table 234. South Korea Biobanking, by Ownership USD Million (2020-2025)
  • Table 235. South Korea Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 236. South Korea Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 237. Taiwan Biobanking, by Type USD Million (2020-2025)
  • Table 238. Taiwan Biobanking, by Application USD Million (2020-2025)
  • Table 239. Taiwan Biobanking, by Ownership USD Million (2020-2025)
  • Table 240. Taiwan Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 241. Taiwan Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 242. Australia Biobanking, by Type USD Million (2020-2025)
  • Table 243. Australia Biobanking, by Application USD Million (2020-2025)
  • Table 244. Australia Biobanking, by Ownership USD Million (2020-2025)
  • Table 245. Australia Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 246. Australia Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 247. Rest of Asia-Pacific Biobanking, by Type USD Million (2020-2025)
  • Table 248. Rest of Asia-Pacific Biobanking, by Application USD Million (2020-2025)
  • Table 249. Rest of Asia-Pacific Biobanking, by Ownership USD Million (2020-2025)
  • Table 250. Rest of Asia-Pacific Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 251. Rest of Asia-Pacific Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 252. Europe Biobanking, by Country USD Million (2020-2025)
  • Table 253. Europe Biobanking, by Type USD Million (2020-2025)
  • Table 254. Europe Biobanking, by Application USD Million (2020-2025)
  • Table 255. Europe Biobanking, by Ownership USD Million (2020-2025)
  • Table 256. Europe Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 257. Europe Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 258. Germany Biobanking, by Type USD Million (2020-2025)
  • Table 259. Germany Biobanking, by Application USD Million (2020-2025)
  • Table 260. Germany Biobanking, by Ownership USD Million (2020-2025)
  • Table 261. Germany Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 262. Germany Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 263. France Biobanking, by Type USD Million (2020-2025)
  • Table 264. France Biobanking, by Application USD Million (2020-2025)
  • Table 265. France Biobanking, by Ownership USD Million (2020-2025)
  • Table 266. France Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 267. France Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 268. Italy Biobanking, by Type USD Million (2020-2025)
  • Table 269. Italy Biobanking, by Application USD Million (2020-2025)
  • Table 270. Italy Biobanking, by Ownership USD Million (2020-2025)
  • Table 271. Italy Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 272. Italy Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 273. United Kingdom Biobanking, by Type USD Million (2020-2025)
  • Table 274. United Kingdom Biobanking, by Application USD Million (2020-2025)
  • Table 275. United Kingdom Biobanking, by Ownership USD Million (2020-2025)
  • Table 276. United Kingdom Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 277. United Kingdom Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 278. Netherlands Biobanking, by Type USD Million (2020-2025)
  • Table 279. Netherlands Biobanking, by Application USD Million (2020-2025)
  • Table 280. Netherlands Biobanking, by Ownership USD Million (2020-2025)
  • Table 281. Netherlands Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 282. Netherlands Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 283. Rest of Europe Biobanking, by Type USD Million (2020-2025)
  • Table 284. Rest of Europe Biobanking, by Application USD Million (2020-2025)
  • Table 285. Rest of Europe Biobanking, by Ownership USD Million (2020-2025)
  • Table 286. Rest of Europe Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 287. Rest of Europe Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 288. MEA Biobanking, by Country USD Million (2020-2025)
  • Table 289. MEA Biobanking, by Type USD Million (2020-2025)
  • Table 290. MEA Biobanking, by Application USD Million (2020-2025)
  • Table 291. MEA Biobanking, by Ownership USD Million (2020-2025)
  • Table 292. MEA Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 293. MEA Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 294. Middle East Biobanking, by Type USD Million (2020-2025)
  • Table 295. Middle East Biobanking, by Application USD Million (2020-2025)
  • Table 296. Middle East Biobanking, by Ownership USD Million (2020-2025)
  • Table 297. Middle East Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 298. Middle East Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 299. Africa Biobanking, by Type USD Million (2020-2025)
  • Table 300. Africa Biobanking, by Application USD Million (2020-2025)
  • Table 301. Africa Biobanking, by Ownership USD Million (2020-2025)
  • Table 302. Africa Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 303. Africa Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 304. North America Biobanking, by Country USD Million (2020-2025)
  • Table 305. North America Biobanking, by Type USD Million (2020-2025)
  • Table 306. North America Biobanking, by Application USD Million (2020-2025)
  • Table 307. North America Biobanking, by Ownership USD Million (2020-2025)
  • Table 308. North America Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 309. North America Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 310. United States Biobanking, by Type USD Million (2020-2025)
  • Table 311. United States Biobanking, by Application USD Million (2020-2025)
  • Table 312. United States Biobanking, by Ownership USD Million (2020-2025)
  • Table 313. United States Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 314. United States Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 315. Canada Biobanking, by Type USD Million (2020-2025)
  • Table 316. Canada Biobanking, by Application USD Million (2020-2025)
  • Table 317. Canada Biobanking, by Ownership USD Million (2020-2025)
  • Table 318. Canada Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 319. Canada Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 320. Mexico Biobanking, by Type USD Million (2020-2025)
  • Table 321. Mexico Biobanking, by Application USD Million (2020-2025)
  • Table 322. Mexico Biobanking, by Ownership USD Million (2020-2025)
  • Table 323. Mexico Biobanking, by Biobank Type USD Million (2020-2025)
  • Table 324. Mexico Biobanking, by Specimen Type USD Million (2020-2025)
  • Table 325. Research Programs/Design for This Report
  • Table 326. Key Data Information from Secondary Sources
  • Table 327. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biobanking: by Type USD Million (2014-2019)
  • Figure 5. Global Biobanking: by Application USD Million (2014-2019)
  • Figure 6. Global Biobanking: by Ownership USD Million (2014-2019)
  • Figure 7. Global Biobanking: by Biobank Type USD Million (2014-2019)
  • Figure 8. Global Biobanking: by Specimen Type USD Million (2014-2019)
  • Figure 9. South America Biobanking Share (%), by Country
  • Figure 10. Asia Pacific Biobanking Share (%), by Country
  • Figure 11. Europe Biobanking Share (%), by Country
  • Figure 12. MEA Biobanking Share (%), by Country
  • Figure 13. North America Biobanking Share (%), by Country
  • Figure 14. Global Biobanking share by Players 2019 (%)
  • Figure 15. Global Biobanking share by Players (Top 3) 2019(%)
  • Figure 16. Global Biobanking share by Players (Top 5) 2019(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Hamilton Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Hamilton Company (United States) Revenue: by Geography 2019
  • Figure 20. Brooks Automation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Brooks Automation (United States) Revenue: by Geography 2019
  • Figure 22. Qiagen N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Qiagen N.V. (Germany) Revenue: by Geography 2019
  • Figure 24. TTP Labtech Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. TTP Labtech Ltd (United Kingdom) Revenue: by Geography 2019
  • Figure 26. VWR Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. VWR Corporation (United States) Revenue: by Geography 2019
  • Figure 28. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2019
  • Figure 30. Tecan Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Tecan Group Ltd. (Switzerland) Revenue: by Geography 2019
  • Figure 32. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Promega Corporation (United States) Revenue: by Geography 2019
  • Figure 34. Worthington Industries (United States) Revenue, Net Income and Gross profit
  • Figure 35. Worthington Industries (United States) Revenue: by Geography 2019
  • Figure 36. Chart Industries (United Sates) Revenue, Net Income and Gross profit
  • Figure 37. Chart Industries (United Sates) Revenue: by Geography 2019
  • Figure 38. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 39. Becton, Dickinson and Company (United States) Revenue: by Geography 2019
  • Figure 40. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 41. Merck KGaA (Germany) Revenue: by Geography 2019
  • Figure 42. Global Biobanking: by Type USD Million (2020-2025)
  • Figure 43. Global Biobanking: by Application USD Million (2020-2025)
  • Figure 44. Global Biobanking: by Ownership USD Million (2020-2025)
  • Figure 45. Global Biobanking: by Biobank Type USD Million (2020-2025)
  • Figure 46. Global Biobanking: by Specimen Type USD Million (2020-2025)
  • Figure 47. South America Biobanking Share (%), by Country
  • Figure 48. Asia Pacific Biobanking Share (%), by Country
  • Figure 49. Europe Biobanking Share (%), by Country
  • Figure 50. MEA Biobanking Share (%), by Country
  • Figure 51. North America Biobanking Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Hamilton Company (United States)
  • Brooks Automation (United States)
  • Qiagen N.V. (Germany)
  • TTP Labtech Ltd (United Kingdom)
  • VWR Corporation (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Tecan Group Ltd. (Switzerland)
  • Promega Corporation (United States)
  • Worthington Industries (United States)
  • Chart Industries (United Sates)
  • Becton, Dickinson and Company (United States)
  • Merck KGaA (Germany)
Additional players considered in the study are as follows:
Modul-Bio (France) , CSols Ltd (United Kingdom), Ziath (United Kingdom) , LabVantage Solutions Inc. (United States) , Greiner Bio-One (Austria) , Biokryo GmbH (Germany) , Biobank AS (Norway) , Biorep Technologies Inc. (United States) , Cell & Co Bioservices (France) , RUCDR infinite biologics (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation